NEXEL is making human cells for testing toxicity of new drug candidates. From human pluripotent stem cells, we are manufacturing pure population of human hepatocytes (Hepatosight-S®), cardiomyocytes (Cardiosight-S®) and neurocyte (Neurosight-S®).

NEXEL provides the Hepatosight-S®, Cardiosight-S®, and Neurosight-S® as frozen vial stocks in liquid nitrogen for the wide range of applications such as toxicity tests of new drug candidates, drug screening, and other research that need human hepatocytes and cardiomyocytes.